N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

Name: N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
License: Public Domain

ImmunityBio, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

glioblastoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 394750
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.